InsiderTrades

Kiselak Tomas

SEC CIK 1830177 · EDGAR

Buying vs selling by month open-market trades, last 37 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ORKAOruka Therapeutics, Inc.Dir, 10% 1.13M — — 32024-09-112025-09-17
DNTHDianthus Therapeutics, Inc. /DE/Dir, 10% 0 $1.06M — 52023-09-122024-09-27

Most active insiders at ORKA, 12 months

#InsiderTitleBoughtSold
1 Fairmount Funds Management LLCDir, 10% —$300.01M
2 Dambkowski CarlDir —$8.65M
3 Klein Lawrence OttoCEO, Dir —$7.31M
4 Quinlan Paul TGC —$6.76M
5 Goncalves JoanaChief Medical Off —$4.54M
6 Agarwal ArjunSVP, Fin —$4.33M
7 Sandler Laura LeeCOO —$1.94M
8 Edwards Larry ToddChief Commercial Off ——

Kiselak Tomas made no open-market trades at ORKA in the last 12 months.

Transactions 8

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
I 2025-09-19 2025-09-17 ORKA Oruka Therapeutics, Inc. Kiselak Tomas Dir, 10% A - Grant $15.00 +333.3K 1.13M +42% +$5.00M
DI 2024-11-21 2024-11-19 ORKA Oruka Therapeutics, Inc. Kiselak Tomas Dir, 10% M - OptEx — +160.0K 798.6K +25% —
I 2024-10-01 2024-09-27 DNTH Dianthus Therapeutics, Inc. /DE/ Kiselak Tomas Dir J - Other $0.00 -62.1K 0 -100% $0
DI 2024-09-13 2024-09-11 ORKA Oruka Therapeutics, Inc. Kiselak Tomas Dir, 10% A - Grant $23.00 +275.0K 638.6K +76% +$6.33M
MI 2024-04-01 2024-04-01 DNTH Dianthus Therapeutics, Inc. /DE/ Kiselak Tomas Dir, 10% J - Other — 0 0 New —
I 2023-09-28 2023-09-26 DNTH Dianthus Therapeutics, Inc. /DE/ Kiselak Tomas Dir, 10% P - Purchase $13.15 +30.0K 1.90M +2% +$394.5K
I 2023-09-21 2023-09-19 DNTH Dianthus Therapeutics, Inc. /DE/ Kiselak Tomas Dir, 10% P - Purchase $13.20 +30.0K 1.87M +2% +$396.0K
DMI 2023-09-13 2023-09-12+ DNTH Dianthus Therapeutics, Inc. /DE/ Kiselak Tomas Dir, 10% P - Purchase $11.20 +24.3K 1.83M +1% +$271.7K

Purchase Sale Sale after option exercise All abbreviations